ArthroLab Inc.   Report issue

For profit Phase 3
Founded: Montreal Canada (1994)

Organization Overview

First Clinical Trial
2008
NCT00604539
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

celecoxib (celebrex) (1 trial)

chondroitin (1 trial)

diacerein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 3)

Joint Diseases (Phase 3)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Synovitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3